LIPTA M 500 IR

# Linagliptin 2.5 mg + Metformin 500 mg ## Short Description **Linagliptin 2.5 mg + Metformin 500 mg** is an oral antidiabetic combination used to help control **blood glucose levels in adults with type 2 diabetes mellitus** when diet and exercise alone are not sufficient. **Linagliptin** is a DPP-4 inhibitor that increases glucose-dependent insulin release and reduces glucagon secretion. **Metformin** decreases glucose production by the liver and improves the body's sensitivity to insulin. > **Important:** The exact dosing schedule depends on the formulation and whether the patient is already taking linagliptin or metformin. Follow the prescribed product instructions. --- ## Key Benefits * Helps improve **blood sugar control** in type 2 diabetes * Combines two complementary glucose-lowering mechanisms * Helps reduce excessive glucose production by the liver * Improves insulin sensitivity * Linagliptin enhances glucose-dependent insulin secretion * May reduce glucagon release when blood glucose is elevated * Linagliptin generally has a **low risk of hypoglycemia when used alone or with metformin** * Linagliptin does not usually require dose adjustment solely because of reduced kidney function --- ## Uses / Indications ### **Type 2 Diabetes Mellitus** Linagliptin + metformin is used as an adjunct to: * A healthy diet * Regular physical activity * Weight-management measures where appropriate It may be prescribed when blood glucose is not adequately controlled with metformin alone or when combination therapy is clinically appropriate. ### Combination Diabetes Treatment The combination may be used: * In patients inadequately controlled on metformin * In patients already receiving linagliptin and metformin as separate medicines * Alongside certain other diabetes medicines when additional glucose control is required ### Not Intended for Type 1 Diabetes This combination is **not a substitute for insulin in type 1 diabetes mellitus**. It is also not intended to treat diabetic ketoacidosis. --- ## How It Works ### Linagliptin 2.5 mg Linagliptin is a **DPP-4 inhibitor**. DPP-4 normally breaks down incretin hormones such as GLP-1 and GIP. By inhibiting DPP-4, linagliptin increases the activity of these hormones. This helps: * Increase insulin release when blood glucose is elevated * Reduce glucagon secretion when glucose is high * Improve overall blood glucose control ### Metformin 500 mg Metformin is a **biguanide antidiabetic medicine**. It primarily: * Reduces glucose production by the liver * Improves insulin sensitivity * Increases peripheral glucose uptake * Helps reduce blood glucose without directly stimulating insulin secretion ### Combined Action **Linagliptin → enhances glucose-dependent insulin response** **Metformin → reduces liver glucose production + improves insulin sensitivity** **Combined effect → improved blood glucose control** --- ## Dosage & Administration > **Important:** The strength listed as **linagliptin 2.5 mg + metformin 500 mg** may be part of a particular fixed-dose formulation. Dosing depends on the formulation, kidney function, previous treatment, and whether immediate-release or extended-release metformin is used. ### Adults The usual total daily amount of linagliptin when used for type 2 diabetes is **5 mg once daily**. Some fixed-dose combination products provide linagliptin 2.5 mg per tablet and are therefore taken according to their specific formulation instructions. Metformin dosing is individualized and generally increased gradually when necessary to improve tolerability. **Do not determine the number of tablets solely from the individual ingredient strengths. Follow the prescription and product label.** ### Administration * Take exactly as prescribed. * Metformin-containing products are generally taken **with meals** to reduce gastrointestinal side effects. * If the product is extended-release, swallow it whole unless the product instructions specifically allow otherwise. * Do not crush, chew, or split modified-release tablets unless permitted by the manufacturer. * Maintain a healthy diet and regular physical activity as advised. ### Missed Dose Take the missed dose when remembered unless it is almost time for the next scheduled dose. **Do not double the next dose.** --- ## Side Effects ### Common Side Effects Possible side effects include: * Nausea * Diarrhea * Abdominal discomfort * Bloating * Flatulence * Reduced appetite * Headache * Upper respiratory symptoms Gastrointestinal effects are particularly common when starting or increasing **metformin**. ### Vitamin B12 Deficiency Long-term metformin use can reduce vitamin B12 levels in some patients. Healthcare professionals may consider periodic **vitamin B12 monitoring**, particularly in people with anemia, neuropathy, or other risk factors. ### Hypoglycemia Linagliptin + metformin alone generally has a relatively low risk of hypoglycemia because linagliptin's insulin-enhancing effect is glucose-dependent. However, the risk can increase when combined with: * Insulin * Sulfonylureas such as glimepiride or gliclazide * Other glucose-lowering medicines ### Serious Side Effects Seek immediate medical attention for symptoms suggestive of **lactic acidosis**, such as: * Severe weakness * Persistent vomiting * Abdominal discomfort * Rapid or difficult breathing * Unusual sleepiness * Dizziness * Feeling unusually cold * Slow or irregular heartbeat Lactic acidosis is rare but potentially life-threatening. Other serious reactions may include severe allergic reactions or pancreatitis. --- ## Precautions & Warnings ### Kidney Function Metformin is eliminated primarily through the kidneys. Kidney function should be assessed before and during treatment. Metformin is generally contraindicated when **eGFR is below 30 mL/min/1.73 m²**, and initiation is generally not recommended at eGFR 30–45 mL/min/1.73 m². Dose and continuation decisions should be individualized by a healthcare professional. ### Lactic Acidosis The risk of metformin-associated lactic acidosis increases with conditions that cause significant tissue hypoxia, impaired kidney function, severe liver disease, dehydration, or excessive alcohol intake. ### Dehydration Severe vomiting, diarrhea, fever, or inadequate fluid intake can increase the risk of kidney problems and metformin-related complications. ### Iodinated Contrast Procedures Metformin may need to be temporarily discontinued around certain **iodinated contrast imaging procedures**, depending on kidney function and the specific procedure. Follow the instructions provided by your healthcare team. ### Surgery Tell your healthcare professional that you take metformin before major surgery or procedures requiring restricted food and fluid intake. ### Pancreatitis DPP-4 inhibitors have been associated with reports of acute pancreatitis. Seek medical attention for persistent, severe abdominal pain, particularly if it radiates to the back and is accompanied by vomiting. ### Heart Failure Tell your doctor if you have heart failure or a history of significant cardiovascular disease. ### Liver Disease Tell your healthcare professional if you have liver disease. ### Alcohol Excessive alcohol intake can increase the risk of **metformin-associated lactic acidosis** and should be avoided. ### Pregnancy If you are pregnant, planning pregnancy, or breastfeeding, discuss diabetes treatment with your healthcare professional. ### Type 1 Diabetes Linagliptin + metformin should not be used to treat type 1 diabetes or diabetic ketoacidosis. --- ## Drug Interactions ### Insulin and Sulfonylureas Combining linagliptin with insulin or sulfonylureas may increase the risk of **hypoglycemia**. Dose adjustments may be necessary. ### Rifampicin Rifampicin can reduce linagliptin exposure and may decrease its glucose-lowering effect. ### Cimetidine Cimetidine can affect metformin elimination and may increase metformin exposure. ### Carbonic Anhydrase Inhibitors Medicines such as **topiramate, acetazolamide, and zonisamide** may increase the risk of metabolic acidosis when used with metformin. ### Iodinated Contrast Media Certain iodinated contrast procedures may temporarily require interruption of metformin because of the risk of acute kidney injury and lactic acidosis. ### Alcohol Excessive alcohol intake can increase the risk of metformin-associated lactic acidosis. ### Other Diabetes Medicines Tell your doctor if you also take: * SGLT2 inhibitors * GLP-1 receptor agonists * Thiazolidinediones * Meglitinides * Other DPP-4 inhibitors Avoid duplicating DPP-4 inhibitor therapy unless specifically directed. Always inform your healthcare professional about **all prescription medicines, over-the-counter medicines, vitamins, minerals, and herbal supplements** you use. --- ## Storage Information * Store at the temperature recommended by the manufacturer. * Keep in the original packaging. * Protect from excessive heat and moisture. * Keep away from direct sunlight. * Keep the container tightly closed. * Keep out of reach and sight of children. * Do not use after the expiry date. * Do not use tablets from damaged or tampered packaging. --- ## Prescription Status **Linagliptin + Metformin is generally a prescription-only medicine.** Because diabetes treatment requires individualized dosing and monitoring of blood glucose, kidney function, and other health factors, it should be used under the supervision of a qualified healthcare professional. --- ## Genuine Medicine Assurance When purchasing **Linagliptin 2.5 mg + Metformin 500 mg**: * Purchase only from a **licensed pharmacy or authorized medicine supplier**. * Check the exact strength and formulation. * Verify the manufacturer's name and details. * Check the batch/lot number and expiry date. * Ensure the packaging and seal are intact. * Check whether the product is immediate-release or extended-release. * Avoid medicines from unauthorized or suspicious sources. * Do not use products with damaged or tampered packaging. * If authenticity is uncertain, consult a pharmacist or contact the manufacturer using the information printed on the package. --- # FAQ – Linagliptin 2.5 mg + Metformin 500 mg ### 1. What is Linagliptin 2.5 mg + Metformin 500 mg used for? It is used to improve **blood glucose control in adults with type 2 diabetes mellitus**, together with diet and exercise. ### 2. Is Linagliptin + Metformin a diabetes medicine? Yes. It is an oral antidiabetic combination containing a **DPP-4 inhibitor (linagliptin)** and a **biguanide (metformin)**. ### 3. How does Linagliptin work? Linagliptin inhibits DPP-4, increasing incretin activity and helping the body release insulin in a glucose-dependent manner while reducing glucagon secretion when blood glucose is elevated. ### 4. How does Metformin work? Metformin mainly reduces **glucose production by the liver** and improves insulin sensitivity, helping the body use glucose more effectively. ### 5. Can this medicine treat Type 1 diabetes? **No.** Linagliptin + metformin is intended for type 2 diabetes and is not a replacement for insulin in type 1 diabetes. ### 6. Does Linagliptin + Metformin lower blood sugar? Yes. The two medicines work through different mechanisms to help reduce elevated blood glucose. ### 7. Does this medicine cause low blood sugar? When used alone, the risk is generally low. However, hypoglycemia becomes more likely when it is combined with **insulin or sulfonylureas**. ### 8. Does Metformin cause stomach problems? Yes. Nausea, diarrhea, abdominal discomfort, and bloating are common, particularly when treatment is first started. Taking metformin with meals can improve tolerability. ### 9. Can Metformin cause vitamin B12 deficiency? Long-term metformin treatment can reduce vitamin B12 levels in some patients. Periodic monitoring may be appropriate depending on individual risk factors. ### 10. Can Linagliptin + Metformin cause weight gain? Metformin is generally weight-neutral or may be associated with modest weight loss. Linagliptin is also generally considered weight-neutral, although individual responses vary. ### 11. Can people with kidney disease take this medicine? Metformin requires particular caution in reduced kidney function. Kidney function should be checked regularly, and metformin use may be restricted at lower eGFR levels. ### 12. Is Linagliptin safe for the kidneys? Linagliptin is primarily eliminated through non-renal pathways and generally does not require dose adjustment solely because of reduced kidney function. However, the **metformin component still requires kidney-function assessment**. ### 13. Can I take this medicine with insulin? It may be used with insulin in some treatment plans, but the combination can increase the risk of hypoglycemia. Your doctor may adjust the insulin dose. ### 14. Can I take Linagliptin + Metformin with glimepiride? It may be prescribed in selected patients, but combining glucose-lowering medicines can increase the risk of hypoglycemia, particularly because of glimepiride. ### 15. Can I drink alcohol while taking Metformin? Avoid excessive alcohol. Heavy alcohol consumption can increase the risk of **lactic acidosis**. ### 16. Should I take Linagliptin + Metformin with food? Metformin is generally taken **with meals** to reduce gastrointestinal side effects. Follow the instructions for your particular formulation. ### 17. Can I crush the tablet? If the product is an extended-release formulation, **do not crush or chew it** unless the manufacturer specifically states that it is permitted. Check the product label. ### 18. What should I do if I miss a dose? Take it when remembered unless it is nearly time for the next dose. **Do not take a double dose.** ### 19. What happens if I take too much Metformin? A large metformin overdose can cause serious complications, including **lactic acidosis**. Seek urgent medical attention if an overdose is suspected. ### 20. What are the symptoms of metformin-associated lactic acidosis? Possible symptoms include severe weakness, unusual sleepiness, vomiting, abdominal discomfort, difficulty breathing, dizziness, feeling cold, and slow or irregular heartbeat. This requires **urgent medical attention**. ### 21. Can Linagliptin cause pancreatitis? Pancreatitis has been reported with DPP-4 inhibitors. Seek medical attention for persistent severe abdominal pain, especially if it radiates to the back. ### 22. Can pregnant women take Linagliptin + Metformin? Diabetes treatment during pregnancy requires individualized medical management. Discuss the medicine with your healthcare professional if you are pregnant or planning pregnancy. ### 23. Can breastfeeding mothers take this medicine? Discuss use during breastfeeding with your healthcare professional, who can consider the benefits and potential risks. ### 24. Is Linagliptin + Metformin a combination of two diabetes medicines? Yes. It combines **linagliptin and metformin**, which lower blood glucose through complementary mechanisms. ### 25. Can I take another DPP-4 inhibitor with Linagliptin? Generally, there is no reason to combine two DPP-4 inhibitors. Do not take another medicine containing linagliptin or another DPP-4 inhibitor unless specifically instructed. ### 26. Does Linagliptin + Metformin cure diabetes? **No.** It helps control blood glucose but does not cure type 2 diabetes. Long-term management may include medication, healthy eating, physical activity, weight management, and regular monitoring. ### 27. How long does it take for this medicine to work? Metformin and linagliptin begin affecting glucose metabolism after treatment starts, but the full effect on long-term glucose control is assessed over time using blood glucose and HbA1c measurements. ### 28. Can I stop taking the medicine when my blood sugar improves? Do not stop it without medical advice. Improved glucose levels may be the result of the treatment working. ### 29. Is Linagliptin 2.5 mg + Metformin 500 mg available without a prescription? It is generally a **prescription medicine**, although regulations vary by country and specific product. ### 30. What monitoring is needed while taking this medicine? Depending on your condition, monitoring may include **blood glucose, HbA1c, kidney function, vitamin B12 levels, and other diabetes-related parameters**. --- ## Medical Disclaimer This information about **Linagliptin 2.5 mg + Metformin 500 mg** is provided for **educational and informational purposes only** and is not a substitute for professional medical advice, diagnosis, or treatment. The exact dosing schedule depends on the specific fixed-dose formulation, whether it is immediate-release or extended-release, kidney function, previous diabetes treatment, and individual blood glucose control. **Do not determine your tablet frequency solely from the individual ingredient strengths.** Metformin can rarely cause serious **lactic acidosis**, particularly in patients with significant kidney impairment or other risk factors. Linagliptin may rarely be associated with pancreatitis. Regular diabetes monitoring and appropriate medical follow-up are important. Do not stop, start, or change diabetes medication without consulting your doctor or pharmacist. Seek urgent medical attention for severe hypoglycemia, symptoms of lactic acidosis, severe allergic reactions, or persistent severe abdominal pain. Always follow the prescribing information supplied with your specific product and the advice of your healthcare professional.